Gland Pharma Ltd
NSE:GLAND
Gland Pharma Ltd
NSE:GLAND
Price:
1 750.6
INR
-1.14%
Market Closed
Market Cap:
288.4B
INR
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
20.4
Current
20.2
Median
12.8
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=20.4
Enterprise Value
/
259B INR
EBITDA
12.7B INR
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
16.5
2-Years Forward
EV/EBITDA
13.9
3-Years Forward
EV/EBITDA
11.4
You don't have any saved screeners yet
